Kolmar BNH Q1 2026 Swings to Profit: Operating Income KRW 10.3B

Q1 2026 consolidated: Revenue KRW 136.9B, OP KRW 10.3B, Net profit KRW 22.3B (vs. FY2025 net loss of KRW 22.6B; includes gain from sale of Colmarsk stake)
Debt ratio improved to 57.3% from 82.8% at FY2025 end (total debt KRW 216.2B, equity KRW 377.3B)
Core segments: health functional foods (60.3%) and cosmetics (36.2%)
R&D expense KRW 2.8B (2.2% of sales); 77 registered patents
Ongoing management control dispute lawsuits (shareholder proposals, court orders) → risk factor
Separate financials: OP KRW 8.9B, Net profit KRW 0.8B (vs. FY2025 net loss of KRW 52.5B)
Completed sale of subsidiary Colmarsk (excluded from consolidation)

ADVERTISEMENT (250px+)